Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes
Thomas E. Delea(Policy Analysis (United States)), Lawrence S. Phillips(University at Buffalo, State University of New York), May Hagiwara(Clinical Research Organization), Gerry Oster(Policy Analysis (United States)), John Edelsberg(University of Washington Medical Center)
Cited by 216
Related Papers
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2006|1.3k
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
|CHEST Journal|2002|1.3k
Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
|New England Journal of Medicine|2006|985
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
|Journal of Clinical Oncology|2001|682